Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells. (Q40287051)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 April 2006

Language	Label	Description	Also known as
English	Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.	scientific article published on 27 April 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

James A. McCubrey

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Bertrand FE

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Steelman LS

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chappell WH

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Abrams SL

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Shelton JG

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

White ER

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ludwig DL

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 April 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1254-1260

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404217

0 references

Clinical trials of antibody therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Anticancer antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

The insulin-like growth factor system in regulation of normal and malignant hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

The insulin-like growth factor system and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

The IGF‐1 receptor in cancer biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

IGF1 and leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404217

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dimensions Publication ID

0 references

release_grsrv35airfgribunqoj4ktaoa

1 reference

https://api.fatcat.wiki/v0/release/grsrv35airfgribunqoj4ktaoa

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40287051&oldid=1839615228"